Baotou Dongbao Bio-Tech Co.,Ltd.’s Net Profit Rose 576.2% in First Three Quarters of 2022

Baotou Dongbao Bio-Tech Co.,Ltd. (包头东宝生物技术股份有限公司) (300239.SZ) reported a net profit of 92.4 million yuan in the first three quarters of 2022, up 576.2% year-on-year.

Meanwhile, the company posted 706 million yuan in revenue, up 71.3% year-on-year.

At the end of the reporting period, it had 2.2 billion yuan in total assets and 486.4 million yuan in total liabilities, with a liability-to-asset ratio of 21.9%.